Work

A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032)

Year: 2022

Type: article

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-022-12762-z

Authors: Areeba Saif, Emily A. Verbus, Amber Leila Sarvestani, Martha E. Teke, Jacob Lambdin, Jonathan M. Hernandez, David G. Kirsch

Institutions: National Institutes of Health, National Cancer Institute, Duke University, Duke Medical Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Varian Medical Systems, Sarcoma Alliance for Research through Collaboration, National Institutes of Health, Stand Up To Cancer

Award: G9000231893

OpenAlex ID: W4309236447

FWCI: 1.842

Cites: 6

Cited by: 16

Related to: 10